@RajJ928 More important question may be: why would you want to stop denosumab? What are indications? Interestingly, romo may be suitable after dmab https://t.co/DOg07M01dy
RT @laiagifre1: Great information obtained from https://t.co/VsbO6iJ1Fg PMO treated with: Romoso->Dmab->Romoso vs. Romoso->placebo-> romoso…
RT @laiagifre1: Great information obtained from https://t.co/VsbO6iJ1Fg PMO treated with: Romoso->Dmab->Romoso vs. Romoso->placebo-> romoso…
RT @laiagifre1: Great information obtained from https://t.co/VsbO6iJ1Fg PMO treated with: Romoso->Dmab->Romoso vs. Romoso->placebo-> romoso…
RT @laiagifre1: Great information obtained from https://t.co/VsbO6iJ1Fg PMO treated with: Romoso->Dmab->Romoso vs. Romoso->placebo-> romoso…
RT @laiagifre1: Great information obtained from https://t.co/VsbO6iJ1Fg PMO treated with: Romoso->Dmab->Romoso vs. Romoso->placebo-> romoso…
Great information obtained from https://t.co/VsbO6iJ1Fg PMO treated with: Romoso->Dmab->Romoso vs. Romoso->placebo-> romoso. Changes in BMD, BTM, sequential therapy, retreat with romoso. Can romoso avoid the increased bone remodelling and bone
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab. Kendler DL et al. Osteoporos Int. 2019 Oct 18 https://t.co/XU4iRXvn9X https://t.co/NtAzquKB8i